Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study. [electronic resource] by
- Lopci, E
- Santi, I
- Derenzini, E
- Fonti, C
- Savelli, G
- Bertagna, F
- Bellò, M
- Botto, B
- Huglo, D
- Morschhauser, F
- Zinzani, P
- Fanti, S
Producer: 20101207
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
|
6.
|
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. [electronic resource] by
- Zinzani, P L
- Venturini, F
- Stefoni, V
- Fina, M
- Pellegrini, C
- Derenzini, E
- Gandolfi, L
- Broccoli, A
- Argnani, L
- Quirini, F
- Pileri, S
- Baccarani, M
Producer: 20100622
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
|
7.
|
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. [electronic resource] by
- Derenzini, E
- Fina, M P
- Stefoni, V
- Pellegrini, C
- Venturini, F
- Broccoli, A
- Gandolfi, L
- Pileri, S
- Fanti, S
- Lopci, E
- Castellucci, P
- Agostinelli, C
- Baccarani, M
- Zinzani, P L
Producer: 20100927
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
|
8.
|
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. [electronic resource] by
- Zinzani, P L
- Tani, M
- Fanti, S
- Stefoni, V
- Musuraca, G
- Castellucci, P
- Marchi, E
- Farsad, M
- Fina, M
- Pellegrini, C
- Alinari, L
- Derenzini, E
- de Vivo, A
- Bacci, F
- Pileri, S
- Baccarani, M
Producer: 20080416
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 19
Availability: No items available.
|
|
|
9.
|
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). [electronic resource] by
- Zinzani, P L
- Derenzini, E
- Pellegrini, C
- Rigacci, L
- Fabbri, A
- Gandolfi, L
- Argnani, L
- Casadei, B
- Pulsoni, A
- Gobbi, M
- Perotti, A
- Zaccaria, A
- Voso, M T
- Cabras, M G
- De Renzo, A
Producer: 20120612
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
10.
|
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. [electronic resource] by
- Zinzani, P L
- Tani, M
- Pulsoni, A
- De Renzo, A
- Stefoni, V
- Broccoli, A
- Montini, G C
- Fina, M
- Pellegrini, C
- Gandolfi, L
- Cavalieri, E
- Torelli, F
- Scopinaro, F
- Argnani, L
- Quirini, F
- Derenzini, E
- Rossi, M
- Pileri, S
- Fanti, S
- Baccarani, M
Producer: 20120522
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
11.
|
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue. [electronic resource] by
- Ciavarella, S
- Vegliante, M C
- Fabbri, M
- De Summa, S
- Melle, F
- Motta, G
- De Iuliis, V
- Opinto, G
- Enjuanes, A
- Rega, S
- Gulino, A
- Agostinelli, C
- Scattone, A
- Tommasi, S
- Mangia, A
- Mele, F
- Simone, G
- Zito, A F
- Ingravallo, G
- Vitolo, U
- Chiappella, A
- Tarella, C
- Gianni, A M
- Rambaldi, A
- Zinzani, P L
- Casadei, B
- Derenzini, E
- Loseto, G
- Pileri, A
- Tabanelli, V
- Fiori, S
- Rivas-Delgado, A
- López-Guillermo, A
- Venesio, T
- Sapino, A
- Campo, E
- Tripodo, C
- Guarini, A
- Pileri, S A
Producer: 20191125
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
12.
|
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue. [electronic resource] by
- Ciavarella, S
- Vegliante, M C
- Fabbri, M
- De Summa, S
- Melle, F
- Motta, G
- De Iuliis, V
- Opinto, G
- Enjuanes, A
- Rega, S
- Gulino, A
- Agostinelli, C
- Scattone, A
- Tommasi, S
- Mangia, A
- Mele, F
- Simone, G
- Zito, A F
- Ingravallo, G
- Vitolo, U
- Chiappella, A
- Tarella, C
- Gianni, A M
- Rambaldi, A
- Zinzani, P L
- Casadei, B
- Derenzini, E
- Loseto, G
- Pileri, A
- Tabanelli, V
- Fiori, S
- Rivas-Delgado, A
- López-Guillermo, A
- Venesio, T
- Sapino, A
- Campo, E
- Tripodo, C
- Guarini, A
- Pileri, S A
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 12 2019
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|